News

6th International Workshop on Clinical Pharmacology of Tuberculosis Drugs September 9, 2013 in Denver, CO.


27 Aug 2013
by Working Group

Image Courtesy of Expert Medical Education

This interactive workshop is held in conjunction with the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The workshop is intended to provide clinicians, researchers, students and representatives from regulatory non-government organizations active in the TB-field with a platform for presentation and discussion of the latest scientific developments in the field. The workshop will allow participants to create a dialog about new potential treatments for TB. Organizers include experts from Radboud University, Global Alliance for TB Drug Development, and Johns Hopkins School of Medicine.

For more information please visit the event website.


More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...